Jump to navigation Jump to search
This article needs additional citations for verification. (August 2014) (Learn how and when to remove this template message)
|AHFS/Drugs.com||Micromedex Detailed Consumer Information|
|Protein binding||76% (trovafloxacin)|
|Metabolism||Quickly hydrolyzed to trovafloxacin|
|Elimination half-life||9 to 12 hours (trovafloxacin)|
|Excretion||Fecal and renal (trovafloxacin)|
|Chemical and physical data|
|Molar mass||558.509 g/mol|
|3D model (JSmol)|
|‹See TfM› (what is this?)|
Trovafloxacin and alatrofloxacin were both withdrawn from the U.S. market in June of 2006.
- "Center for Drug Evaluation and Research – Application Number: 020759/020760 – Chemistry Review(s)" (PDF). Food and Drug Administration. Retrieved 29 August 2014.
|This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.|